NexImmune, Inc. (NASDAQ:NEXI – Get Rating) shares were up 4.3% during trading on Friday . The stock traded as high as $0.40 and last traded at $0.40. Approximately 38,026 shares traded hands during trading, a decline of 96% from the average daily volume of 1,065,892 shares. The stock had previously closed at $0.38. NexImmune Stock […]
NexImmune, Inc. (NASDAQ:NEXI – Get Rating) was the target of a large drop in short interest during the month of March. As of March 15th, there was short interest totalling 344,000 shares, a drop of 18.1% from the February 28th total of 419,800 shares. Approximately 2.0% of the company’s shares are short sold. Based on […]
NexImmune, Inc. (NASDAQ:NEXI – Get Rating) saw a large increase in short interest in the month of March. As of March 31st, there was short interest totalling 865,000 shares, an increase of 46.6% from the March 15th total of 590,000 shares. Based on an average daily volume of 191,100 shares, the days-to-cover ratio is presently […]
NexImmune (NASDAQ:NEXI – Get Rating) had its target price boosted by Barclays from $4.00 to $7.00 in a report issued on Friday, The Fly reports. They currently have an overweight rating on the stock. Several other equities analysts have also recently weighed in on the stock. Cantor Fitzgerald reiterated an overweight rating on shares of […]